International Clinical Trial: Study on the Early Warning, Prediction of Clinical Outcomes and Influencing Factors of Metabolic-Associated Fatty Liver Disease (MAFLD) in Patients with Chronic Hepatitis B Virus Infection

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132922) titled 'Study on the Early Warning, Prediction of Clinical Outcomes and Influencing Factors of Metabolic-Associated Fatty Liver Disease (MAFLD) in Patients with Chronic Hepatitis B Virus Infection' on Sept. 20.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Second Affiliated Hospital of Chongqing Medical Universityity

Condition: Chronic Hepatitis B, Metabolic associated fatty liver

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2023-05-01

Target Sample Size: Observation group of chronic hepatitis B combined with metabolic-associated fatty liver disease:500;...